[1]
2021. Treatment of family hypercholesterolemia with PCSK9 inhibitors: an integrative review. Research, Society and Development. 10, 15 (Nov. 2021), e233101523018. DOI:https://doi.org/10.33448/rsd-v10i15.23018.